{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:36:52Z","timestamp":1790681812791,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.imbio.2010.12.001","type":"journal-article","created":{"date-parts":[[2010,12,12]],"date-time":"2010-12-12T04:04:58Z","timestamp":1292126698000},"page":"847-853","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Passive vaccination with a human monoclonal antibody: Generation of antibodies and studies for efficacy in Bacillus anthracis infections"],"prefix":"10.1016","volume":"216","author":[{"given":"Ulrich","family":"vor dem Esche","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Zgaga-Griesz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Grunow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Beyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang G.","family":"Bessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.imbio.2010.12.001_bib0005","doi-asserted-by":"crossref","first-page":"6231","DOI":"10.1128\/IAI.70.11.6231-6241.2002","article-title":"Post exposure prophylaxis against anthrax: evaluation of various treatment regimens in intranasally infected guinea pigs","volume":"70","author":"Altboum","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.imbio.2010.12.001_bib0010","first-page":"127","article-title":"The lipopeptide P3CSK4 constitutes an adjuvant in parenteral and oral immunization","volume":"6","author":"Baier","year":"1997","journal-title":"Vaccine Res."},{"issue":"3","key":"10.1016\/j.imbio.2010.12.001_bib0015","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/20014091096738","article-title":"Anthrax toxin","volume":"27","author":"Bhatnagar","year":"2001","journal-title":"Crit. Rev. Microbiol."},{"key":"10.1016\/j.imbio.2010.12.001_bib0020","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/n35101999","article-title":"Identification of the cellular receptor for anthrax toxin","volume":"414","author":"Bradley","year":"2001","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.imbio.2010.12.001_bib0025","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1086\/427189","article-title":"Late treatment with a protective antigen-directed monoclonal antibody improves hemodynamic function and survival in a lethal toxin-infused rat model of anthrax sepsis","volume":"191","author":"Cui","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.imbio.2010.12.001_bib0030","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/0076-6879(87)52074-2","article-title":"Use of eukaryotic expression technology in the functional analysis of cloned genes","volume":"152","author":"Cullen","year":"1987","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.imbio.2010.12.001_bib0035","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1126\/science.280.5364.734","article-title":"Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor","volume":"280","author":"Duesbery","year":"1998","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.imbio.2010.12.001_bib0040","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1093\/infdis\/167.5.1239","article-title":"Post exposure prophylaxis against experimental inhalation anthrax","volume":"167","author":"Friedlander","year":"1993","journal-title":"J. Infect. Dis."},{"issue":"7","key":"10.1016\/j.imbio.2010.12.001_bib0045","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1128\/IAI.71.7.3831-3836.2003","article-title":"Salmonella enterica Serovar Typhimurium expressing a chromosomally integrated copy of the Bacillus anthracis protective antigen gene protects mice against an anthrax spore challenge","volume":"71","author":"Garmory","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.imbio.2010.12.001_bib0050","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1016\/j.vaccine.2007.01.056","article-title":"Monitoring of ELISA-reactive antibodies against anthrax protective antigen (PA), lethal factor (LF), and toxin-neutralising antibodies in serum of individuals vaccinated against anthrax with the PA-based UK anthrax vaccine","volume":"25","author":"Grunow","year":"2007","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.imbio.2010.12.001_bib0055","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ijmm.2003.12.002","article-title":"Protection of mice against challenge with Bacillus anthracis STI spores after DNA vaccination","volume":"294","author":"Hahn","year":"2004","journal-title":"Int. J. Med. Microbiol."},{"key":"10.1016\/j.imbio.2010.12.001_bib0060","first-page":"211","article-title":"Antigens combined with or conjugated to lipopeptides constitute potent immunogens for in vitro and in vivo immunizations and for the preparation of human and murine monoclonal antibodies","volume":"181","author":"Hoffmann","year":"1990","journal-title":"Immunobiology"},{"issue":"3","key":"10.1016\/j.imbio.2010.12.001_bib0065","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3233\/HAB-1990-1304","article-title":"Preparation of human and murine monoclonal antibodies: antigens combined with or conjugated to lipopeptides constitute potent immunogens for in vitro and in vivo immunizations","volume":"1","author":"Hoffmann","year":"1990","journal-title":"Hum. Antibod. Hybridomas"},{"key":"10.1016\/j.imbio.2010.12.001_bib0070","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0022-1759(96)00121-4","article-title":"Murine bone marrow-derived macrophages constitute feeder cells for human B cell hybridomas","volume":"196","author":"Hoffmann","year":"1996","journal-title":"J. Immunol. Methods"},{"issue":"3","key":"10.1016\/j.imbio.2010.12.001_bib0075","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1128\/jb.94.3.609-614.1967","article-title":"Antibiotic treatment of anthrax infection in mice","volume":"94","author":"Jones","year":"1967","journal-title":"J. Bacteriol."},{"issue":"9","key":"10.1016\/j.imbio.2010.12.001_bib0080","doi-asserted-by":"crossref","first-page":"4997","DOI":"10.1128\/IAI.70.9.4997-5007.2002","article-title":"Anthrax edema toxin requires influx of calcium for inducing cyclic AMP toxicity in target cells","volume":"70","author":"Kumar","year":"2002","journal-title":"Infect. Immun."},{"issue":"10","key":"10.1016\/j.imbio.2010.12.001_bib0085","doi-asserted-by":"crossref","first-page":"6547","DOI":"10.1128\/IAI.73.10.6547-6551.2005","article-title":"An anthrax lethal factor-neutralizing monoclonal antibody protects rats before and after challenge with anthrax toxin","volume":"73","author":"Lim","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.imbio.2010.12.001_bib0090","series-title":"Microbial Toxins: Current Research and Future Trends","isbn-type":"print","author":"Maldonado-Arocho","year":"2009","ISBN":"https:\/\/id.crossref.org\/isbn\/9781904455448"},{"issue":"6","key":"10.1016\/j.imbio.2010.12.001_bib0095","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nbt0602-597","article-title":"Protection against anthrax toxin by recombinant antibody fragments correlates with antigen affinity","volume":"20","author":"Maynard","year":"2002","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.imbio.2010.12.001_bib0100","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1128\/IAI.72.6.3276-3283.2004","article-title":"Enhancement of anthrax lethal toxin cytotoxicity: a subset of monoclonal antibodies against protective antigen increases lethal toxin-mediated killing of murine macrophages","volume":"72","author":"Mohamed","year":"2004","journal-title":"Infect. Immun."},{"key":"10.1016\/j.imbio.2010.12.001_bib0105","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/n35101998","article-title":"Crystal structure of the anthrax lethal factor","volume":"414","author":"Pannifer","year":"2001","journal-title":"Nature"},{"issue":"5589","key":"10.1016\/j.imbio.2010.12.001_bib0110","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1126\/science.1073163","article-title":"Macrophage apoptosis by anthrax lethal factor through p38 MAP kinase inhibition","volume":"297","author":"Park","year":"2002","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.imbio.2010.12.001_bib0115","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0378-1119(88)90501-X","article-title":"Nucleotide sequence of the Bacillus anthracis edema factor gene (cya): a calmodulin-dependent adenylate cyclase","volume":"73","author":"Robertson","year":"1988","journal-title":"Gene"},{"key":"10.1016\/j.imbio.2010.12.001_bib0120","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0022-1759(88)90206-2","article-title":"The high efficiency, human B cell immortalizing heteromyeloma CB-F7","volume":"106","author":"Grunow","year":"1988","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.imbio.2010.12.001_bib0125","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/path.1700730219","article-title":"The pathogenesis of anthrax following the administration of spores by respiratory route","volume":"73","author":"Ross","year":"1957","journal-title":"J. Pathol. Bacteriol."},{"issue":"1","key":"10.1016\/j.imbio.2010.12.001_bib0130","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1476-8518-2-5","article-title":"Human anti-anthrax protective antigen neutralizing monoclonal antibodies derived from donors vaccinated with anthrax vaccine adsorbed","volume":"2","author":"Sawada-Hirai","year":"2004","journal-title":"J. Immune Based Ther. Vaccines"},{"issue":"1","key":"10.1016\/j.imbio.2010.12.001_bib0135","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0166-0934(98)00072-X","article-title":"Human monoclonal anti-HCMV neutralizing antibody from phage display libraries","volume":"74","author":"Takekoshi","year":"1998","journal-title":"J. Virol. Methods"},{"issue":"4","key":"10.1016\/j.imbio.2010.12.001_bib0140","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3233\/HAB-2003-12404","article-title":"Neutralizing monoclonal antibody against anthrax lethal factor inhibits intoxication in a mouse model","volume":"12","author":"Zhao","year":"2003","journal-title":"Hum. Antibodies"}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298510002172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298510002172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:26:56Z","timestamp":1759249616000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171298510002172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0171298510002172"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2010.12.001","relation":{},"ISSN":["0171-2985"],"issn-type":[{"value":"0171-2985","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Passive vaccination with a human monoclonal antibody: Generation of antibodies and studies for efficacy in Bacillus anthracis infections","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2010.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}